Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their prescribed obesity medication, according to findings published in Obesity. Researchers from Cleveland Clinic analyzed electronic health record data to identify adults with overweight or obesity who used semaglutide (Ozempic/Wegovy, Novo Nordisk) or tirzepatide (Mounjaro/Zepbound,
In this large, nationwide population-based cohort study, a preconception BMI in the category of underweight, overweight, or obesity in either or both parents was associated…
The absence of high BP, hyperlipidemia, underweight or overweight, diabetes and smoking could extend life expectancy by more than a decade, researchers reported.In addition, improvement…
A new AI model accurately detected cardiac amyloidosis from echocardiograms with higher accuracy vs. other amyloidosis risk scores, according to research published in the European…
AbstractObjective. Surveillance is often adopted for asymptomatic non-functioning pituitary macroadenomas (macroNFPAs). Due to low-quality evidence, uncert
Connect with your peers year-round by joining one of our new Special Interest Groups (SIGs). These members-only communities are created to foster connections and share…
T1D Fellows 2025 Psychosocial Care Molly Tanenbaum, PhD Jul. 15, 2025, 9:00 AM – 10:30
Connect with fellow experts – from bench to bedside – on the latest in adrenal and pituitary science and care.
